Table 4

Health outcomes during 6 week monitoring period (ORs (95% CIs) for association with proximity to opencast sites)

		Community		95% CI		Children (n)
		Pair^4-150	Opencast	95% CI		Children (n)		Control	OR^4-151
Prevalence of diary symptoms (%):
Wheeze	1 to 5	4	4	0.82	0.36 to 1.89	1405
Cough		1,2,4,5	15	17	0.96	0.79 to 1.16	1405
Cough		3	16	8	1.99	1.31 to 3.01
Other respiratory symptom^4-152		1,3,4,5	17	15	1.26	0.99 to 1.61	1405
Other respiratory symptom^4-152		2	16	19	0.80	0.66 to 0.97
Asthma reliever used^4-153		1,2	24	37	0.66	0.33 to 1.26	224⁴
Asthma reliever used^4-153		3	31	13	4.32	1.12 to 16.7
GP consultations (n/person-year):
All		1,2,3,4	2.7	2.4	1.10	0.94 to 1.29	2442
All		5	2.2	4.6	0.43	0.24 to 0.78
Respiratory, skin, eye		1,2,3,4	2.1	1.5	1.40	1.15 to 1.70	2442
Respiratory, skin, eye		5	0.9	3.8	0.16	0.06 to 0.40
Respiratory		1,2,3,4	1.5	1.1	1.42	1.13 to 1.79	2442
Respiratory		5	0.7	3.2	0.15	0.06 to 0.43

↵4-150 Different community groupings are the result of significant interactions found in the statistical analysis.
↵4-151 Association with community type having adjusted for covariates pair, sex, housing tenure, age and asthma.
↵4-152 Sore throat, ear ache, runny ear or nose.
↵4-153 Numbers in pairs 4 and 5 too few to be analysed.
4-154 Children, who ever had asthma.